Informations sur le produit
Nom :
Sipatrigine
Synonymes :
- 2-(4-Methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-4-pyrimidinamine
- 2-(4-Methyl-piperazin-1-yl)-5-(2,3,5-trichloro-phenyl)-pyrimidin-4-ylamine
- 2-(4-Methylpiperazin-1-Yl)-5-(2,3,5-Trichlorophenyl)-Pyrimidin-4-Amine
- 4-Pyrimidinamine, 2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-
- 619C89
- Bw 619C89
- L-Glutamic Acid, N-[4-[2-(2-Amino-4,7-Dihydro-4-8 Oxo-1H-Pyrrolo[2,3-D] Pyrimidin-5-Yl)Ethyl]Benzoyl]-, Disodium Salt, Heptahydrate
- disodium (2S)-2-[({4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)amino]pentanedioate
Description :
Sipatrigine is a drug that belongs to the group of pharmacological agents. It has been shown to have neuroprotective and anti-epileptic effects in animal models. Sipatrigine inhibits voltage-gated potassium channels, slowing the influx of calcium ions into nerve cells and preventing neuronal cell death. It is also an inhibitor of glutamate release, which may contribute to its therapeutic effects. Sipatrigine has a side-effect profile similar to lamotrigine, with the exception of being less sedating.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
372.68 g/mol
Formule :
C15H16Cl3N5
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
